| Economic and Financial Impacts of Cancer | Lifetime | 88 | US 55 | 98.49 |
| Pharmaceutical Economics and Policy | Lifetime | 94 | US 51 | 98.29 |
| Health and Medical Research Impacts | Lifetime | 78 | US 44 | 97.39 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 738 | US 338 | 98.34 |
| Biomedical Ethics and Regulation | Lifetime | 117 | US 71 | 96.14 |
| Pharmaceutical industry and healthcare | Lifetime | 85 | US 58 | 96.52 |
| Biosimilars and Bioanalytical Methods | Lifetime | 219 | US 78 | 96.14 |
| Statistical Methods in Clinical Trials | Lifetime | 256 | US 138 | 96.62 |
| Diversity and Career in Medicine | Lifetime | 355 | US 260 | 95.26 |
| Healthcare cost, quality, practices | Lifetime | 420 | US 234 | 94.96 |
| Advanced Breast Cancer Therapies | Lifetime | 570 | US 251 | 95.56 |
| Advances in Oncology and Radiotherapy | Lifetime | 378 | US 180 | 93.38 |
| Ethics in Clinical Research | Lifetime | 582 | US 322 | 92.59 |
| Meta-analysis and systematic reviews | Lifetime | 750 | US 235 | 91.95 |
| Social Media in Health Education | Lifetime | 477 | US 259 | 88.62 |
| Academic Publishing and Open Access | Lifetime | 166 | US 48 | 83.19 |
| Hospital Admissions and Outcomes | Lifetime | 759 | US 520 | 82.50 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 38 | US 11 | 99.22 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 11 | US 7 | 99.39 |
| Pharmaceutical Economics and Policy | 2021-2025 | 9 | US 4 | 98.59 |
| Statistical Methods in Clinical Trials | 2021-2025 | 8 | US 4 | 98.46 |
| Cancer Genomics and Diagnostics | 2021-2025 | 112 | US 61 | 99.10 |
| Biomedical Ethics and Regulation | 2021-2025 | 12 | US 7 | 96.20 |
| Cancer Treatment and Pharmacology | 2021-2025 | 182 | US 57 | 96.45 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 554 | US 190 | 96.51 |
| Social Media in Health Education | 2021-2025 | 52 | US 21 | 92.52 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 445 | US 196 | 95.56 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 137 | US 55 | 92.74 |
| Advanced Breast Cancer Therapies | 2021-2025 | 276 | US 102 | 95.14 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 527 | US 163 | 93.83 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 409 | US 185 | 92.67 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 505 | US 242 | 93.19 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 943 | US 218 | 87.85 |
| Pharmaceutical industry and healthcare | 2021-2025 | 50 | US 22 | 85.27 |
| Advanced Causal Inference Techniques | 2021-2025 | 174 | US 106 | 85.52 |
| Healthcare cost, quality, practices | 2021-2025 | 536 | US 222 | 78.37 |
| Ethics in Clinical Research | 2021-2025 | 628 | US 267 | 78.40 |
| Academic Publishing and Open Access | 2021-2025 | 53 | US 5 | 77.19 |
| Meta-analysis and systematic reviews | 2021-2025 | 556 | US 106 | 78.96 |